Literature DB >> 12418520

Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats.

Irene T Lee1, Julie K Levy, Shawn P Gorman, P Cynda Crawford, Margaret R Slater.   

Abstract

OBJECTIVE: To determine prevalence of FeLV infection and serum antibodies against feline immunodeficiency virus (FIV) in unowned free-roaming cats.
DESIGN: Cross-sectional serologic survey. ANIMALS: 733 unowned free-roaming cats in Raleigh, NC, and 1,143 unowned free-roaming cats in Gainesville, Fla.
RESULTS: In Raleigh, overall prevalence of FeLV infection was 5.3%, and overall seroprevalence for FIV was 2.3%. In Gainesville, overall prevalence of FeLV infection was 3.7%, and overall seroprevalence for FIV was 4.3%. Overall, FeLV prevalence was 4.3%, and seroprevalence for FIV was 3.5%. Prevalence of FeLV infection was not significantly different between males (4.9%) and females (3.8%), although seroprevalence for FIV was significantly higher in male cats (6.3%) than in female cats (1.5%). CONCLUSIONS AND CLINICAL RELEVANCE: Prevalence of FeLV infection and seroprevalence for FIV in unowned free-roaming cats in Raleigh and Gainesville are similar to prevalence rates reported for owned cats in the United States. Male cats are at increased risk for exposure to FIV, compared with female cats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12418520     DOI: 10.2460/javma.2002.220.620

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  24 in total

Review 1.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Concomitant feline immunodeficiency virus (FIV) and Mycoplasma haemofelis in a barn cat.

Authors:  Alejandra Ceballos-Vasquez
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

3.  Insertional polymorphisms of endogenous feline leukemia viruses.

Authors:  Alfred L Roca; William G Nash; Joan C Menninger; William J Murphy; Stephen J O'Brien
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  WSAVA Guidelines for the vaccination of dogs and cats.

Authors:  M J Day; M C Horzinek; R D Schultz; R A Squires
Journal:  J Small Anim Pract       Date:  2016-01       Impact factor: 1.522

5.  Feline immunodeficiency virus testing in stray, feral, and client-owned cats of Ottawa.

Authors:  Susan E Little
Journal:  Can Vet J       Date:  2005-10       Impact factor: 1.008

6.  The variability of serological and molecular diagnosis of feline immunodeficiency virus infection.

Authors:  D Bienzle; F Reggeti; X Wen; S Little; J Hobson; S Kruth
Journal:  Can Vet J       Date:  2004-09       Impact factor: 1.008

7.  A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.

Authors:  Géraldine Schlecht-Louf; Marianne Mangeney; Hanane El-Garch; Valérie Lacombe; Hervé Poulet; Thierry Heidmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  Epizootiology and management of feline leukemia virus in the Florida puma.

Authors:  Mark W Cunningham; Meredith A Brown; David B Shindle; Scott P Terrell; Kathleen A Hayes; Bambi C Ferree; R T McBride; Emmett L Blankenship; Deborah Jansen; Scott B Citino; Melody E Roelke; Richard A Kiltie; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Wildl Dis       Date:  2008-07       Impact factor: 1.535

Review 9.  Emerging viruses in the Felidae: shifting paradigms.

Authors:  Stephen J O'Brien; Jennifer L Troyer; Meredith A Brown; Warren E Johnson; Agostinho Antunes; Melody E Roelke; Jill Pecon-Slattery
Journal:  Viruses       Date:  2012-02-07       Impact factor: 5.048

10.  Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011).

Authors:  Bimal K Chhetri; Olaf Berke; David L Pearl; Dorothee Bienzle
Journal:  BMC Vet Res       Date:  2013-01-05       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.